Zhandos Burkitbayev

1 та иш

National Research Oncology Center LLP, Astana 010000, Kazakhstan

1. The Role of CD56 as an Immunophenotypic Marker in the Clinical Course of Multiple Myeloma

   Azat Karabekov, Vadim Kemaikin, Zhandos Burkitbayev +15

   МақолаMultiple Myeloma Research and TreatmentsJournal of Clinical Medicine20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.015051